Zum Hauptinhalt springen
Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Für diesen Artikel ist leider kein Bild verfügbar.

Stem Cells and Small RNAs

From Molecular Basis to Clinical Trials

(Autor)

Buch | Hardcover
416 Seiten
2016
Academic Press Inc (Verlag)
978-0-12-800651-1 (ISBN)
CHF 137,90 inkl. MwSt
  • Titel wird leider nicht erscheinen
  • Artikel merken

Contents

Part I: Small RNAs

1. Outline

2. Rational design and high efficiency of siRNAs and shRNAs



Molecular structures of small RNAs
Working mechanisms of sRNAs
Essential factors of rational design
Biological traits of sRNAs with high efficiency
Gene regulation of endogenous sRNAs

3. Side-effects of siRNA and shRNA



Off-targets
Identification of off-target effect
Immune stimulatory effects
Toxic effects of sRNA

4. miRNAs regulating noncoding and coding mRNAs



Working principles of miRNAs
Regulation of miRNA expression
Discovery of ALU-based miRNAs
Function of ALU-based miRNAs
miRNA drugs

5. Discovery and functions of endogenous short-hairpin RNAs



Discovery of endogenous shRNAs in human
Silencing models of endogenous shRNAs
Physiological function of endogenous shRNA
Difference between endogenous shRNAs and miRNAs
Evolution of shRNAs

6. Transfection of siRNAs into floating cells or stem cells



Current issues of delivery systems
Liposome-based transfection reagents
Polymer-based veihcal
Virus -based transduction methods
Peptide nanoparticals

7. Transdermal delivery of small RNAs in vivo



Injection of Nude siRNAs
Cholesterol-conjugated siRNAs
Transdermal and Mucusal delivery
Inhalation aerosols
Stable Nucleic Acid Lipid Particle (SNALP)

8. sRNAs and stem cells



sRNA-omics of stem cells
Regulation of stem cell self-renewal by sRNAs
sRNA-mediated modulation on stem cell differentiation

9. siRNA gene drugs



RNAi-mediated validation of genes as drug targets
Special traits of siRNA-based drugs
Clinical trials of siRNA drugs
Development of siRNA drugs in China

Part II: Stem Cells

1. Oultines

2. Embryonic stem cells



Derivation of human embryonic stem cell lines
Phenotypic analysis of human ESCs
Genetic and epigenetic analysis of human ESCs
ESC self-renewal and differentiation
RNAi in ESCs

3. Adult stem cells



Isolation and identification of MSCs from different sources
Large-scale expansion of MSCs
Identification and characterization of MSCs
Senescence of MSCs
Immuno-modulation and homing of MSCs
Genetically engineering MSCs

4. Induced pluripotent stem cells



Concept of reprogramming
Phenotypic analysis of human iPSCs
Genetic and epigenetic traits of human iPSCs
Molecular mechanisms of reprogramming
Human iPSC-based disease model for drug discovery

5. Trans-determination of stem cells



Conversion of MSCs to neural stem cells
Differentiation of MSCs to Cardiac stem cells
Conversion of MSCs to endothelial stem cells
Hepatogenic differentiation of MSCs
Transformation of MSCs to pancreatic stem cells

6. Induced hematopoietic stem cells



Conversion of MSCs into HSCs
Immunocytochemical analysis of human stem cells
Analysis of genome-wide gene expression profiles
In vitro colony-forming assay
In vivo reconstitution of marrow functions
Classical cytogenetics: karyotyping

7. Cancer stem cells



Isolation and characterization of CSCs
Enrichment and culture of CSCs
Molecular basis of CSC resistance
Migration of CSCs
Signaling networks of CSCs

8. Molecular mechanisms of trans-determination



Concept of transdetermination state
Genetic and epigenetic analysis of transdetermination
Difference between reprogramming, de-differentiating and transdetermining
Signaling networks of transdetermination
Prospective importance of transdetermination

9. Stem cell drugs in China



Concept of stem cell drugs
R&D of Stem cell drugs
Basic facilities and conditions
Clinical studies
Regulation of stem cell drugs

Part III three: Methods

1. Isolation, characterization and maintenance of MSCs

2. Approaches for derivation and expansion of HSCs

3. Activation of MSC transdetermination state

4. Bioinformatics of transdetermination

Microarray approach to identify signaling pathways responsible for transdetermination

5. Approaches for enrichment, characterization, and maintenance of cancer stem cells

6. Technologies to generate iPS cells



Genetic engneering
mRNA inducing methods
miRNAs
Small molecules

6. Microarrays of small RNAs

7. Molecular sensors detecting small RNAs

8. Micro-analysis of stem cell biological trails

9. Gene-modified stem cells

10. Clinical grade generation of stem cells

Part IV: Application

1. Outlines

2. siRNA-based de-pigmenting and brightening cosmetics

3. siRNA treatment in psoriases model

4. miRNA and heart disease

5. MSC-derived HSCs transplantation

6. MSC-derived RBCs for fabrication of blood

7. MSC-derived RBCs for generation of platelets

8. MSC-derived RBCs for production of CIK cells

9. MSC-derived neural stem cells for cerebral palsy

10. Anti-aging application of MSCs

11. MSC-derived pancreatic stem cells and diabetes

Erscheint lt. Verlag 13.5.2016
Verlagsort San Diego
Sprache englisch
Maße 152 x 229 mm
Themenwelt Naturwissenschaften Biologie Genetik / Molekularbiologie
Naturwissenschaften Biologie Zellbiologie
ISBN-10 0-12-800651-X / 012800651X
ISBN-13 978-0-12-800651-1 / 9780128006511
Zustand Neuware
Informationen gemäß Produktsicherheitsverordnung (GPSR)
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
An Introduction

von Jens Kurreck; Cy Aaron Stein

Buch | Softcover (2025)
Wiley-VCH (Verlag)
CHF 146,95

von Elisabeth Knust; Hans-Arno Müller; Wilfried Janning

Buch | Softcover (2025)
Springer Berlin (Verlag)
CHF 69,95